| Financial Year |
March 31 2022 |
| Monetary Funds |
687,496,820.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
439,592,632.08 |
| Advances to Suppliers |
31,617,561.59 |
| Other Receivables |
52,875,385.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
248,755,375.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,434,374.24 |
| Total Current Assets |
1,497,758,311.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,050,853.80 |
| Investment Properties |
52,433,620.61 |
| Fixed Assetes |
390,864,697.67 |
| Under-construction Projects |
41,329,602.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,043,929.61 |
| R&D expenses |
-- |
| Goodwill |
1,255,833,455.30 |
| Long-Term Deferred and Prepaid Expenses |
21,143,897.12 |
| Deferred Income Tax Assets |
96,136,715.21 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,657,743,486.73 |
| Total Assets |
4,155,501,798.51 |
| Short-Term Loans |
444,341,947.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
291,648,151.98 |
| Accounts Payable |
162,332,944.72 |
| Accounts Received In Advance |
1,963,795.26 |
| Employee Compensation Payable |
40,694,680.73 |
| Taxes Payable |
95,937,905.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
82,923,986.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
227,444,295.87 |
| Other Current Liabilities |
4,003,609.01 |
| Sub-Total of Current Liabilities |
1,403,133,773.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
124,777,431.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
161,616,312.04 |
| Total Liabilities |
1,564,750,085.94 |
| Paid-In Capital(Or Share Stock) |
404,870,487.00 |
| Capital Surplus |
46,447,504.22 |
| Surplus Reserve |
171,539,490.70 |
| LESS:Treasury Stock |
15,593,087.88 |
| Undistributed Profits |
1,942,753,446.59 |
| Minority Stockholder's Interest |
40,727,923.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,550,023,789.50 |
| Owner's Equity（Stockholder's Equity） |
2,590,751,712.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,155,501,798.51 |
